TrialsgrambetaRCTs are beautiful

ALMS

2009

Aspreva Lupus Management Study

In 370 patients with active lupus nephritis, mycophenolate mofetil was non-inferior for induction response and superior for maintenance versus cyclophosphamide then azathioprine.

Result

Primary endpoint: Treatment response at 24 weeks; time to treatment failure

Induction response 56.2% MMF vs 53.0% IV cyclophosphamide; maintenance MMF vs azathioprine HR 0.44 for failure (p<0.001).

Original publication
Subtopic
Lupus nephritis
Design
Open-label RCT (induction and maintenance phases)
Relevance
Important: one of several pillars.
Source
Appel GB, et al. J Am Soc Nephrol. 2009;20(5):1103-1112.doi 10.1681/ASN.2008101028

Discussion & critique

Made MMF an equivalent induction and superior maintenance agent; KDIGO 2024 prefers MMF with low-dose steroids.

Discussed in podcasts